Table 3

Incidences of psychiatric sequelae after propensity score matching

After infection in the matched primary cohort and influenza control cohortAfter infection in the matched primary cohort and RTI control cohort
Acute: 1–3 months after infectionDelayed: 4–6 months after infectionAcute: 1–3 months after infectionDelayed: 4–6 months after infection
Hospitalised with
COVID-19 (n=457)
Hospitalised with influenza (n=457)Hospitalised with
COVID-19 (n=285)
Hospitalised with influenza (n=285)Hospitalised with
COVID-19 (n=597)
Hospitalised with other RTI (n=597)Hospitalised with
COVID-19 (n=333)
Hospitalised with other RTI (n=333)
Mood/anxiety/psychotic disorder167 (36.5)130 (28.4)89 (31.2)74 (26.0)207 (34.7)247 (41.4)104 (31.2)123 (36.9)
Mood disorder92 (20.1)68 (14.9)47 (16.5)39 (13.7)114 (19.1)136 (22.8)53 (15.9)66 (19.8)
Anxiety disorder58 (12.7)55 (12.0)29 (10.2)32 (11.2)75 (12.6)123 (20.6)34 (10.2)55 (16.5)
Psychotic disorder87 (19.0)44 (9.6)42 (14.7)21 (7.4)103 (17.3)121 (20.3)47 (14.1)54 (16.2)
Insomnia282 (61.7)176 (38.5)132 (46.3)108 (37.9)365 (61.1)315 (52.8)148 (44.4)163 (48.9)
  • Values are presented as number (%).

  • COVID-19, coronavirus disease 2019; RTI, respiratory tract infection.